Clinical Trial Update: Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating optimized dynamic neoadjuvant therapy for HER2-positive breast cancer guided by HER2-PET/CT imaging; currently not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING